Back to Atlas
APotentially durableStandard research/education caution
CMP-0101
Research
Osteogenic growth peptide (OGP)
Bone remodeling / Regenerative
May support osteoblast proliferation, bone formation, and skeletal repair signaling
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- Endogenous 14-aa growth peptide; osteoblast and marrow stromal signaling
- Primary market use
- Bone / regenerative
Pharmacology
- Molecular weight (Da)
- ~1,523.8
- Oral bioavailability
- N/A (peptide; not oral)
- Half-life
- Not established; likely short without delivery system
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Preclinical
- Clinical status
- Research
- Value-for-money score
- 4 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Full OGP differs from active OGP(10-14) pentapeptide; human PK not well established